2,150 Shares in Hamilton Lane Incorporated (NASDAQ:HLNE) Acquired by Conservest Capital Advisors Inc.

Conservest Capital Advisors Inc. acquired a new position in shares of Hamilton Lane Incorporated (NASDAQ:HLNEFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 2,150 shares of the company’s stock, valued at approximately $244,000.

Other institutional investors have also modified their holdings of the company. GAMMA Investing LLC purchased a new stake in shares of Hamilton Lane during the 4th quarter worth approximately $48,000. International Assets Investment Management LLC purchased a new stake in shares of Hamilton Lane during the 4th quarter worth approximately $142,000. Nomura Asset Management Co. Ltd. lifted its position in shares of Hamilton Lane by 11.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,609 shares of the company’s stock worth $146,000 after buying an additional 168 shares during the last quarter. CI Investments Inc. purchased a new stake in shares of Hamilton Lane during the 3rd quarter worth approximately $155,000. Finally, Xponance Inc. purchased a new stake in shares of Hamilton Lane during the 4th quarter worth approximately $251,000. Hedge funds and other institutional investors own 97.40% of the company’s stock.

Hamilton Lane Stock Performance

HLNE traded up $1.15 during trading on Friday, hitting $114.53. The stock had a trading volume of 160,552 shares, compared to its average volume of 200,793. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.58 and a current ratio of 2.58. The firm has a market capitalization of $6.19 billion, a P/E ratio of 35.24 and a beta of 1.18. The company’s 50-day moving average price is $111.80 and its 200 day moving average price is $105.76. Hamilton Lane Incorporated has a twelve month low of $62.86 and a twelve month high of $121.90.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.71 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.88 by ($0.17). The firm had revenue of $125.26 million during the quarter, compared to analyst estimates of $130.47 million. Hamilton Lane had a net margin of 25.22% and a return on equity of 28.77%. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.43 earnings per share. On average, equities research analysts forecast that Hamilton Lane Incorporated will post 3.53 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 4th. Shareholders of record on Friday, March 15th were paid a $0.445 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $1.78 annualized dividend and a yield of 1.55%. Hamilton Lane’s dividend payout ratio is currently 54.77%.

Insider Buying and Selling at Hamilton Lane

In other news, major shareholder Oakville Number 2 Trust sold 55,000 shares of the company’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $108.00, for a total transaction of $5,940,000.00. Following the transaction, the insider now directly owns 480,015 shares of the company’s stock, valued at approximately $51,841,620. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 26.82% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. downgraded shares of Hamilton Lane from an “overweight” rating to a “neutral” rating and set a $115.00 price objective for the company. in a research report on Thursday, April 11th. Wells Fargo & Company upped their price target on shares of Hamilton Lane from $106.00 to $111.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 7th. Morgan Stanley upped their price target on shares of Hamilton Lane from $102.00 to $126.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 24th. Oppenheimer downgraded shares of Hamilton Lane from an “outperform” rating to a “market perform” rating in a research report on Thursday, January 11th. Finally, UBS Group upped their price target on shares of Hamilton Lane from $118.00 to $120.00 and gave the company a “neutral” rating in a research report on Friday, April 12th. Six research analysts have rated the stock with a hold rating, According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $109.67.

Check Out Our Latest Stock Report on Hamilton Lane

About Hamilton Lane

(Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Want to see what other hedge funds are holding HLNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hamilton Lane Incorporated (NASDAQ:HLNEFree Report).

Institutional Ownership by Quarter for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.